Funding AI Infrastructure
Meta is making a big push into artificial intelligence, and it is creating a new kind of stock designed to help finance the initiative.
During its third-quarter earnings report, the company announced plans to issue non-voting stock, which does not provide owners with a vote on corporate decisions, to help support its artificial intelligence infrastructure push.
Meta chief financial officer Susan Li stated that the company plans to create a new class of non-voting capital stock to be distributed to existing shareholders through a stock dividend.
The new shares are intended for capital raising, employee compensation, acquisitions, and general corporate purposes while preserving the voting power of existing Class A and Class B shareholders.
The structure allows the company to maintain its founder-led configuration while expanding its funding flexibility to invest in ongoing artificial intelligence developments.
Financial Performance
Meta reported strong quarterly revenue of $64 billion, marking a 26% year-over-year increase, alongside rising costs and expenses that grew by 68% compared to the previous year.
The Reality Labs division, which handles augmented reality and virtual reality hardware and software, continues to experience operating losses, though the company projects those losses to decrease to between $18 billion and $19 billion.
AI Product Growth
Over the past year, Meta has introduced several artificial intelligence models and developer tools, including open-weight parameters and specialized coding agents.
Chief Executive Officer Mark Zuckerberg reported strong initial adoption for the company's personal agent products, noting significant user acquisition within the first month and a half of availability.
With initial product-market fit established, the company is transitioning toward scaling its artificial intelligence services for a broader global audience.
Regulatory Monitoring
The company also acknowledged ongoing monitoring of active legal and regulatory matters, including upcoming youth-related trials in the United States that could impact financial results.
